SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020), Hoffmann M. | AcademicGPT, tlooto

It is demonstrated that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross- (2020), CELL, Hoffmann M. | AcademicGPT, tlooto for Academic and Research